<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28608">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02154516</url>
  </required_header>
  <id_info>
    <org_study_id>2011-ODHH166</org_study_id>
    <nct_id>NCT02154516</nct_id>
  </id_info>
  <brief_title>Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <authority>South Africa: National Health Research Ethics Council</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the early safety and efficacy of a new hard-on-hard
      total hip replacement system in patients with non-inflammatory arthritis.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2011</start_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Revision Rate</measure>
    <time_frame>Up to 2 Years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Reoperations that led to removal or replacement of any of the acetabular or femoral components.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Up to 2 Years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Metal Ion Concentration in Whole Blood</measure>
    <time_frame>Up to 2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Arthritis, Degenerative</condition>
  <arm_group>
    <arm_group_label>Control Total Hip Replacement Device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total Hip replacement surgery using control device consisting of a hard-on-soft bearing or a ceramic-on-ceramic bearing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Investigational Hard-on-Hard Total Hip Replacement Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Total Hip replacement surgery using an experimental device consisting of a hard-on-hard bearing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ODH Hip System</intervention_name>
    <arm_group_label>Control Total Hip Replacement Device</arm_group_label>
    <arm_group_label>Investigational Hard-on-Hard Total Hip Replacement Device</arm_group_label>
    <other_name>Total Hip Replacement</other_name>
    <other_name>THR</other_name>
    <other_name>Total Hip Arthroplasty</other_name>
    <other_name>THA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 21 years old

          -  Skeletally mature

          -  Requires primary, unilateral total hip arthroplasty due to degenerative join disease

          -  Preoperative Harris Hip Score of less than or equal to 70

          -  Meets an acceptable preoperative medical clearance and is free or treated for
             conditions that would pose excessive operative risk

          -  Given consent to participate in the study

          -  Able to understand the purpose of the study, his/her role, and is available for
             follow-up

        Exclusion Criteria:

          -  Diagnosis with high risk of Total Hip Arthroplasty (THA) failure

          -  Requires bilateral THA

          -  Requires revision of a prior hip replacement

          -  Active infection or sepsis

          -  History of local hip infection

          -  Known metastatic or neoplastic disease

          -  Conditions that may interfere with THA survival or outcomes

          -  Need for structural bone grafts to support the implant

          -  Contralateral lower extremity condition

          -  Has other joint replacements or plans for other joint replacements within 2 years

          -  Systemic steroid therapy within 3 months prior to surgery

          -  Life expectancy less than 2 years

          -  Intra-articular therapy within 6 months of enrollment

          -  Female of child-bearing age not using contraception

          -  Inadequate bone stock to support the device

          -  Moderate to severe renal insufficiency

          -  Emotional or neurological condition that would pre-empt ability or willingness to
             participate in the study

          -  BMI &gt;40

          -  Above the knee amputation of the contralateral or ipsilateral leg

          -  Known allergies to the components of the devices

          -  Entered into another investigational study

          -  Is a prisoner
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Entabeni Hospital</name>
      <address>
        <city>Durban</city>
        <zip>4001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zuid Afrikaans Hospital</name>
      <address>
        <city>Pretoria</city>
        <zip>0002</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>May 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
